We are always looking for talented people with the right skillset. Submit your application here, and should any suitable roles be available, we will be in touch.
About Hypervision Surgical
Hypervision Surgical (“Hypervision”) is a spin-out from King’s College London, founded by clinicians and experts in medical imaging and artificial intelligence. Using safe light alone, our mission is to equip surgeons with real-time, AI-driven tissue intelligence to improve precision and patient safety.
We are pioneering the world’s first regulatory-cleared real-time intraoperative spectral imaging platform, combining on-chip spectral sensing with high-speed AI analytics at over 60 frames per second. Seamlessly integrating into existing surgical vision systems, our technology transforms standard cameras into intelligent, data-rich tools — revealing anatomical, physiological, and pathological information beyond human vision.
Certified for both open and minimally invasive surgery, our platform achieved UKCA certification and FDA clearance in 2025 under a newly established AI/ML product code, and was admitted into the FDA’s Safer Technology Program. With multi-centre clinical evaluations underway and strategic partnerships with world-leading technology and surgical manufacturers, including imec and ZEISS Ventures, Hypervision is shaping the future of data-driven surgery.